GLENMEDE TRUST CO NA - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 214 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$18,000
-91.0%
11,558
-60.5%
0.00%
-100.0%
Q4 2020$199,000
-38.6%
29,257
+0.4%
0.00%
-50.0%
Q3 2020$324,000
+76.1%
29,135
-0.7%
0.00%
+100.0%
Q2 2020$184,000
+87.8%
29,335
+0.7%
0.00%
Q1 2020$98,0000.0%29,1350.0%0.00%
Q4 2019$98,000
+58.1%
29,1350.0%0.00%
Q3 2019$62,000
-19.5%
29,1350.0%0.00%
Q2 2019$77,000
-44.2%
29,1350.0%0.00%
-100.0%
Q1 2019$138,000
+100.0%
29,1350.0%0.00%
Q4 2018$69,000
-46.1%
29,1350.0%0.00%
-100.0%
Q3 2018$128,000
-39.0%
29,1350.0%0.00%0.0%
Q2 2018$210,000
+90.9%
29,1350.0%0.00%
Q1 2018$110,0000.0%29,1350.0%0.00%
Q4 2017$110,000
+124.5%
29,1350.0%0.00%
Q3 2017$49,000
-57.4%
29,1350.0%0.00%
-100.0%
Q2 2017$115,0000.0%29,1350.0%0.00%0.0%
Q1 2017$115,000
-19.0%
29,1350.0%0.00%0.0%
Q4 2016$142,000
-36.9%
29,1350.0%0.00%0.0%
Q3 2016$225,000
+38.0%
29,1350.0%0.00%0.0%
Q2 2016$163,000
+4.5%
29,1350.0%0.00%0.0%
Q1 2016$156,000
-38.3%
29,1350.0%0.00%
-50.0%
Q4 2015$253,000
+3.7%
29,1350.0%0.00%0.0%
Q3 2015$244,00029,1350.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders